Sarah Whelan, PhD
Science Writer
at Technology Networks
Sarah joined Technology Networks in 2022 after completing a PhD in cancer biology, where her research focused on the development of colon cancers. In her role as science writer and editor, Sarah covers scientific news and a range of other content types, leading the site's coverage of drug discovery, biopharma and cancer research content.
Education
Areas of Expertise
Got a Question for Sarah Whelan, PhD?
Get in touch using the contact form linked here and we’ll get back to you shortly.

New Alzheimer’s Drug Rejected by European Medicines Agency Committee

New Shingles Vaccine May Cut Risk of Dementia

Study Links Popular Weight Loss Drug to Risk of Rare Blinding Condition

Nearly Half of Cancer Cases Are Linked to Modifiable Risk Factors, Study Finds

RSV Vaccine in Pregnancy Not Associated With Increased Preterm Birth Risk, Study Finds

Antibodies in Screening

Mediterranean Diet Linked to Lower Mortality for Cancer Survivors, Study Finds

New Alzheimer’s Drug Donanemab Approved by FDA

How Algae Microrobots Could Tackle Inflammatory Bowel Disease
